A New Frontier in Alzheimer’s: Blocking Immune Infiltration to Prevent Neurodegeneration
In the decades-long battle against Alzheimer’s disease and related "tauopathies," the scientific community has largely focused on clearing the toxic...
In the decades-long battle against Alzheimer’s disease and related "tauopathies," the scientific community has largely focused on clearing the toxic...
For families navigating the often-harrowing odyssey of undiagnosed rare diseases, the "diagnostic odyssey" is frequently marked by years of medical...
In the delicate dance of cellular life, DNA is constantly under siege. From the constant barrage of environmental stressors to...
In the high-stakes world of biopharmaceutical manufacturing, the focus is often placed on the final molecule—the complex protein therapy that...
This past week, the biotechnology sector witnessed a rare and counterintuitive phenomenon: a significant courtroom victory that translated into a...
As the biopharmaceutical landscape shifts from traditional monoclonal antibodies toward complex viral vectors, mRNA vaccines, and sophisticated cell-based therapies, the...
Every movement a human makes—from the blink of an eye to the stride of an Olympic sprinter—relies on a microscopic,...
In the quest to demystify Alzheimer’s disease, science has long looked to the brain’s neurons as the primary battlefield. However,...
In a significant breakthrough for synthetic biology and antimicrobial research, scientists at the University of Otago—Ōtākou Whakaihu Waka—in New Zealand...
A groundbreaking study led by researchers at the Texas Children’s Duncan Neurological Research Institute (Duncan NRI) at Baylor College of...
Urinary tract infections (UTIs) remain one of the most pervasive clinical challenges in modern medicine. Primarily driven by the uropathogenic...
In a move set to reshape the landscape of high-performance purification technology across the European continent, Pittsburgh-based Thar Process has...